Randomized, controlled trial of amitriptyline versus placebo for adolescents with 'treatment-resistant' major depression

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 37, Issue 5, 1998, Pages 527-535

  Birmaher, Boris ^a,b   Waterman, G Scott ^a   Ryan, Neal D ^a   Perel, James ^a   McNabb, Joanne ^a   Balach, Lisa ^a   Beaudry, Mary Beth ^a   Nasr, Farida N ^a   Karambelkar, Jagannath ^a   Elterich, Gertrude ^a   Quintana, Humberto ^a   Williamson, Douglas E ^a   Rao, Uma ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescents; Antidepressants; Major depressive disorder

Indexed keywords

AMITRIPTYLINE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0031978918     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199805000-00015     Document Type: Article

References (43)

1. Beck AT, Steer RA, Garbin MG (1988), Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 8:77-100
2. Begg CB, Iglewicz B (1980), A treatment allocation procedure for sequential clinical trials. Biometrics 36:81-90
3. Birmaher B, Ryan ND, Williamson DE, Brent DA, Kaufman J (1996), Childhood and adolescent depression: a review of the past 10 years, part II. J Am Acad Child Adolesc Psychiatry 35:1575-1583
4. Boulos C, Kutcher S, Gardner D, Young E (1992), An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. J Child Adolesc Psychopharmacol 2:103-111
5. Brent DA, Holder D, Kolko D et al. (1997), A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive treatments. Arch Gen Psychiatry 54:877-885
6. Chambers WJ, Puig-Antich J, Hirsch M et al. (1985), The assessment of affective disorders in children and adolescents by semistructured interview test-retest reliability of the Schedule for Affective borders and Schizophrenia for School-Age Children, Present Episode version. Arch Gen Psychiatry 42:696-702
7. Clarke GN, Hawkins W, Murphy M, Sheeber LB, Lewinsohn PM, Seeley JR (1995) Targeted prevention of unipolar depressive disorder in an at-risk sample of high school adolescents: a randomized trial of a group cognitive intervention. J Am Acad Child Adolesc Psychiatry 34:312-321
8. Efron B (1971), Forcing a sequential experiment to be balanced. Biometrika 58:403-417
9. Emslie G, Rush AJ, Weinberg AW et al. (1997), A double-blind, randomized placebo-controlled trial of fluoxetine in depressed children and adolescents. Arch Gen Psychiatry 54:1031-1037
10. Geller B (1997), Treatment of major depressive disorders. Presented at Annual Mid-Year Institute of the American Academy of Child and Adolescent Psychiatry, Hamilton, Bermuda
11. Geller B, Cooper T, Graham D, Marsteller FA, Bryant DM (1990), Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull 26:85-90
12. Geller B, Fox LW, Cooper TB, Garrity K (1992), Baseline and 2- to 3-year follow-up characteristics of placebo-washout responders from nortriptyline study of depressed 6- to 12-year-olds. J Am Acad Child Adolesc Psychiatry 31:622-628
13. Geller B, Todd RD, Luby J, Botteron KN (1996), Treatment-resistant depression in children and adolescents. Psychiatr Clin North Am 19: 253-267
14. Ghaziuddin N, Kinc C, Naylor M et al. (1995), Electroconvulsive therapy (ECT) in refractory adolescent depression. Presented at the 42nd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New Orleans
15. Gibbons RD, Hedeker D, Elkin I et al. (1993), Some conceptual and statistical issues in analysis of longitudinal psychiatric data: application to the NIMH Treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry 50:739-750
16. Goldman-Rakic PS, Brown RM (1981), Regional changes of monamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience 6:177-187
17. Guy W (1976), ECDEU Assessment Manual of Psychopharmacology (US Department of Health, Education, and Welfare publication ADM #76-338). Rockville, MD: NIMH, Psychopharmacology Research Branch
18. Hamilton M (1960), A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-61
19. Himmelhoch JM, Garfinkel ME (1986), Sources of lithium resistance in mixed mania. Psychopharmacol Bull 22:613-620
20. Hollingshead AB (1975), Four-Factor Index of Social Status. New Haven, Cl: Yale University Department of Sociology
21. Jacobson NS, Dobson KS, Truax PA et al. (1996), A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol 64: 295-304
22. Krupnick JL, Sotsky SM, Simmens S et al. (1996), The role of the therapeutic alliance in psychotherapy and pharmacotherapy outcome: findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol 64:532-539
23. Kye C, Ryan ND (1995), Pharmacologic treatment of child and adolescent depression. Child Adolesc Psychiatr Clin North Am 4:261-281
24. Lewinsohn PM, Clarke GN, Seeley JR, Rohde P (1994), Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 33:809-818
25. Mantel N (1966), Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170
26. Murrin L, Gibbens D, Ferrer J (1985), Ontogeny of dopamine, serotonin, and spirodecanone receptors to rat forebrain: an autoradiographic study. Brain Res 355:91-109
27. Nordberg A (1986), The aging of cholinergic synapses: ontogenesis of cholinergic receptors. In: Dynamics of Cholinergin Function, Hannin I, ed. New York: Plenum, pp 165-175
28. Orvaschel H, Puig-Antich J (1987), Schedule for Affective Disorders and Schizophrenia for School-Age Children (6-18), Epidemiologic Version, K-SADS-E 4th Version. Fort Lauderdale, FL: Nova University
29. Rey JM, Walter G (1997), Half century of ECT use in young people. Am J Psychiatry 154:595-602
30. Ribeiro SCM, Tandon R, Grunhaus L, Greden JF (1993), The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 150: 1618-1629
31. Ryan N, Meyer V, Decal S, Mazzie D, Puig-Antich J (1988a), Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry 27:371-376
32. Ryan N, Puig-Antich J, Rabinovich H et al. (1988b), MAOIs in adolescent major depression unresponsive to tricyclic antidepressant. J Am Acad Child Adolesc Psychiatry 27:755-758
33. Sallee FR, Vrindavanam NS, Deas-Nesmith D, Carson SW, Sethuraman G (1997), Pulse intravenous clomipramine for depressed adolescents: a double-blind controlled trial. Am J Psychiatry 154:668-673
34. Shaffer D, Gould M, Brasic J et al. (1983), A children's global assessment scale (CGAS). Arch Gen Psychiatry 40:1228-1231
35. Shapiro SS, Wilk MB (1965), An analysis of variance test for normalcy (complete samples). Biometrika 52:591-611
36. Spanier C, Frank E, McEachran AB, Grochocinski VJ, Kupfer DJ (1996), The prophylaxis of depressive episodes in recurrent depression following discontinuation of drug therapy: integrating psychological and biological factors. Psychol Med 26:461-475
37. Spitzer RL, Williams JBW, Gibbon M, First MB (1989), Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II, 9/1/89 Version). New York: Biometrics Research Department, New York State Psychiatric Institute
38. Strober M, Freeman R, Rigali J, Schmidt S, Diamond R (1992), The pharmacotherapy of depressive illness in adolescence II: effects of lithium augmentation in nonresponders to imipramine. J Am Acad Child Adolesc Psychiatry 31:16-20
39. Thase ME, Kupfer DJ, Buysse DJ et al. (1995), Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression, I: comparison during acute depressive states. Biol Psychiatry 38:506-515
40. Thase ME, Rush AJ (1995), Treatment-resistant depression. In: Psychopharmacology: The Fourth Generation of Progress, Bloom FE, Kupfer DJ, eds New York: Raven
41. Weiss M, Gaston L, Propst A, Wisebord S, Zicherman V (1997), The role of the alliance in the pharmacologic treatment of depression. J Clin Psychiatry 58:196-204
42. Wilens T, Biederman J, Baldessarini J et al. (1996), The cardiovascular effects of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry 35:1491-1501
43. Wood A, Harrington R, Moore A (1996), Controlled trial of a brief cognitive-behavioral intervention in adolescent patients with depressive disorders. J Child Psychol Psychiatry 37:737-746